Global Stocks
Live market coverage and equity research across US, GCC, India, Taiwan, Japan, Korea.
Premium tier-1 desk read on Global Stocks.
Free preview, full briefing via Sales.
📊 Expert View — Premium Insight
Tier-1 analyst takes on US tech, GCC sovereign holdings, and Asia-Pacific semi cycle. Contact sales to unlock.
Contact Sales to Unlock📈 Live Market Board
Multi-tab live coverage — US mega-caps, indices, Asia-Pacific, commodities. Toggle between tabs to switch markets.
🌐 Coverage Markets — Detail
🇺🇸 United States
Mega-caps and AI leaders driving the index this cycle: NVIDIA · Apple · Microsoft · Tesla. Watch the AI compute capex theme + datacenter buildout.
🇸🇦 Saudi Arabia (Tadawul)
Vision 2030 plays — Saudi Aramco (oil supply discipline + dividend yield), Al Rajhi Bank (Sharia-compliant retail banking leader). Tadawul All Share Index (TASI) tracks the broader market.
🇦🇪 United Arab Emirates
Dubai Financial Market General Index · ADX General Index — petro-state diversification, tourism + real estate plays.
🇹🇼 Taiwan (TAIEX)
Semiconductor super-cycle: TSMC (leading-edge foundry, AI accelerator orders) · Hon Hai (Foxconn EMS, AI server assembly) · Quanta Computer (server ODM).
🇮🇳 India
NIFTY 50 · BSE Sensex — consumption + IT services + manufacturing PLI scheme localizing semi production.
🇯🇵 Japan / 🇰🇷 Korea
Nikkei 225 (corporate governance reform driving multiples) · KOSPI (semi + EV battery — Samsung / SK Hynix / LG Energy).
Latest in Global Stocks
30 stories
Why Okta Stock Was Rocking it This Week
The company is playing a big role in a new industry alliance aimed at securing AI agents.…
Pharma stock soars 150% on injectables deal with Wegovy maker Novo
Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk.…
Prediction: Adobe Stock Trades Back Above $350 Before 2030
Getting back there takes roughly a 12% annualized gain -- less than the earnings growth the company is already guiding for this year.…
Is SpaceX Stock a Buy, Sell, or Hold Right Now? Here's What I'm Doing.
There are reasons to both buy and sell SpaceX stock.…
$1,000 Invested in Micron Before Sept. 30 Could Be Worth This Much by 2028
Micron looks like a great buy ahead of earnings.…
Will the Nasdaq Fall After the First Interest Rate Hike in 3 Years? History Offers a Strikingly Clear Answer.
Nasdaq companies may be particularly sensitive to interest rate levels.…
Nvidia Raised Its Dividend 2,400%, but a $10,000 Investment Still Pays Just $44 a Year
Earlier this year, Nvidia raised its dividend 25-fold.…
There's a New Threat to the Stock Market and President Donald Trump's Economy
The Federal Reserve may have thrown a monkey wrench of epic proportions into the proverbial engines that power Wall Street and the U.S. economy.…
Why Turning Point Brands Stock Was Sliding This Week
It was an eventful set of days for the company, but not in ways investors appreciated.…
Even With Rising Treasury Yields, I'd Still Rather Buy This Unstoppable Dividend Stock for Passive Income.
Target has become a high-yielding growth-and-income stock.…
Akamai stock is surging. A $12 billion Anthropic deal reveals its powerful edge over cloud providers.
Akamai has agreed to supply cloud computing services to Anthropic.…
Warren Buffett Is Saying Farewell With a Sobering 4-Word Message for Investors
Buffett's investing career is a master class on building wealth in the stock market.…
Why Beta Technologies Stock Was Climbing This Week
The company's aircraft will be used to deliver medical equipment.…
Meta’s Muse AI Downloads Are Soaring. Is It Time to Buy This Bargain AI Stock?
Muse even surpassed ChatGPT as a top free app.…
Here's Why Grail Stock Surged 55% This Week
The company received a favorable vote from the FDA this week, which could open up significant adoption of its multi-cancer early detection test, Galleri.…
Warren Buffett's Successor, Greg Abel, Has 55% of Berkshire Hathaway's $360 Billion Portfolio Invested in 4 Standout Stocks
Approximately $196 billion of Berkshire’s invested assets are concentrated in the Oracle of Omaha’s and Abel’s best ideas.…
After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion…
Where Will Robinhood Stock Be in 5 Years?
The trading platform continues to launch the finance products of the future.…
The Math Doesn't Lie: What Oklo's Stock Sales Actually Cost Investors
Oklo could change the way we use nuclear energy. But getting there hasn't been cheap.…
4 No-Brainer ETFs I'm Buying if the Stock Market Crashes in 2026
These fast-growing ETFs will likely be trading at attractive valuations after a market pullback.…
Costco Just Showed Why It's a Better Buy Than Walmart
Costco delivered another strong earnings report, even as rivals like Walmart are seeing slowing revenue growth.…
Iran says it's up to U.S. to end war as China presses for de-escalation
The remarks came as the Houthis launched a new wave of missile and drone attacks at Saudi targets Friday morning.…
Meta Has Lost More Than $85 Billion on Its Glasses and Headsets. Here's What Would Stop It.
What would it take to stop the losses in the social media giant's hardware unit?…
Is Micron Stock Going to $1,625? 1 Wall Street Analyst Think So.
Micron still has plenty of upside potential.…
Nike and McDonald's Are the Worst-Performing Dow Stocks This Year. Here's the 1 to Buy in October.
The brands share a similar association as titans of American export culture, and the two stocks are struggling now.…
Why Fervo Energy Stock Is Up Today
The geothermal pioneer achieved a major operational milestone.…
Astera Labs vs. Marvell Technology: Which Tech Stock Is a Better Buy in 2026?
Astera Labs boasts higher revenue growth, but customer concentration poses a risk. Marvell trades at lower multiples with broader diversification.…
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?
Revolution Medicines' stock is up 330% in a year on drug development progress; you may want to spread your bets with Royalty Pharma instead.…
Nova's Chief Technology Officer Dumps Nearly 4,000 Shares for $1.4 Million
The CTO divested 15% of his direct holdings as the stock climbed 17% over the past year.…
Prediction: The S&P 500 Finishes 2027 Above 9,000. Here's the Earnings Math.
The prediction needs no richer valuation -- just one more year of double-digit earnings growth after 2027.…